Showing results (21-30 of 72) with videos related to
Sort By:
Pageof 8
Neurology|January 1, 1992
[18F]-6-fluorodopa PET scanning in Parkinson's disease after selective COMT inhibition with nitecapone (OR-462)A Laihinen, J O Rinne, U K Rinne, et al.Acta Physiologica Scandinavica|September 1, 1980
Transcapillary exchange and distribution of carbon-11 labelled ethanol in the isolated perfused rat liverM Kleinänen, J Kuikka, S J Heselius, et al.Annals of Neurology|June 14, 2000
Progression in Parkinson's disease: a positron emission tomography study with a dopamine transporter ligand [18F]CFTE Nurmi, H M Ruottinen, V Kaasinen, et al.Neurology|February 11, 2000
An FDOPA PET study in patients with periodic limb movement disorder and restless legs syndromeH M Ruottinen, M Partinen, C Hublin, et al.Movement Disorders : Official Journal of the Movement Disorder Society|August 2, 2001
Rate of progression in Parkinson's disease: a 6-[18F]fluoro-L-dopa PET studyE Nurmi, H M Ruottinen, J Bergman, et al.Applied Radiation and Isotopes : Including Data, Instrumentation and Methods for Use in Agriculture, Industry and Medicine|May 5, 2009
Positron emission tomography and [18F]BPA: a perspective application to assess tumour extraction of boron in BNCTL Menichetti, L Cionini, W A Sauerwein, et al.Nuclear Medicine and Biology|October 2, 2001
Synthesis of S-([18F]fluoromethyl)-(+)-McN5652 as a potential PET radioligand for the serotonin transporterJ Zessin, O Eskola, P Brust, et al.Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|November 18, 2000
Reproducibility and effect of levodopa on dopamine transporter function measurements: a [18F]CFT PET studyE Nurmi, J Bergman, O Eskola, et al.Diabetes, Obesity & Metabolism|March 5, 2002
2-[(18)F]fluoro-2-deoxy-D-glucose combined with microdialysis can be used for the comparison of tissue glucose metabolism in obese and lean ratsK A Virtanen, M Haaparanta, T Grönroos, et al.Life Sciences|April 20, 1987
Organ and tumor distribution of (18F)-2-fluoro-2-deoxy-D-glucose in fasting and non-fasting ratsR Paul, A Kiuru, K O Söderström, et al.Pageof 8